Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 480 participants.

Also called NCT07932639

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 480 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07932639
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07932639. Randomized; single masking; primary purpose prevention. Start 2026-03-21 (actual); primary completion 2029-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis
Acronym
SPDACSIS-RCT
Condition
Symptomatic Intracranial Atherosclerotic Stenosis
Intervention (Drug)
Cilostazol
Intervention (Drug)
Aspirin
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor
Lead sponsor
Second Affiliated Hospital of Soochow University (class: other)

Record details

Record id
cardio:ct-nct07932639
Content hash
537d16cb430a24c355195a5bdf222fc7d52430db8e3225e5bab047557cd431af